PEDro celebrates Cystic Fibrosis Awareness Month in May 2020

May 2020 is #CFawareness Month, a time for those affected by cystic fibrosis, their families, healthcare team and supporters to raise awareness of the condition. Cystic fibrosis is a progressive, genetic disease that primarily affects the lungs and pancreas, contributing to persistent lung infections and malnutrition. Approximately 70,000 to 100,000 people are currently living with cystic fibrosis worldwide.

Physiotherapists play a significant role in the management of those with cystic fibrosis, including optimising airway clearance techniques and training parents and carers to perform daily prophylactic treatment. Physiotherapists prescribe structured individualised exercise programs to assist with airway clearance, improve strength and fitness, and help manage cystic fibrosis-related diabetes. Participation in these physiotherapy programs can improve the quality of life of those with cystic fibrosis.

There is a significant amount of high-quality clinical research to guide the physiotherapy management of people with cystic fibrosis. PEDro currently indexes over 240 clinical practice guidelines, systematic reviews and randomised controlled trials evaluating physiotherapy treatment for people with cystic fibrosis.

You may like to review the following practice guidelines, which provide useful summaries for physiotherapists working in this clinical area:

The Cochrane Library includes many systematic reviews specific to cystic fibrosis, links to recent reviews are listed below:

To keep up-to-date with the latest trials, reviews and guidelines evaluating physiotherapy interventions for people with cystic fibrosis, subscribe to the ‘cardiothoracic’ or ‘chronic respiratory disease’ feed of PEDro’s Evidence in your inbox. Subscription is free.

Sign up to the PEDro Newsletter to receive the latest news